PharmiNews

Directory of Pharma Companies and News

Company Profile

ABIVAX

ABIVAX logo
Category
ABIVAX is mobilizing the body's natural immune machinery to treat patients with viral infections, autoimmune diseases and cancer. A clinical-stage company, ABIVAX leverages its antiviral and immune enhancing platforms to optimize candidates to cure HIV and treat inflammatory bowel diseases and liver cancer. ABIVAX is listed on Euronext compartment B (ISIN: FR0012333284 - Mnémo: ABVX).
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma